BioArctic AB (BIOA B) NPV

Sell:324.60 SEKBuy:325.00 SEKPrice increased7.40 SEK (2.33%)

Market closed |
Prices delayed by at least 15 minutes
Sell:324.60 SEK
Buy:325.00 SEK
Change:Price increased7.40 SEK (2.33%)
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:324.60 SEK
Buy:325.00 SEK
Change:Price increased7.40 SEK (2.33%)
Market closed |
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open320.60 SEK
Previous close317.60 SEK
Market capSEK 23.60bn
P/E ratio27.51
Volume68,055
Dividend yield0.63%
EMS-

Company information

BioArctic AB is a Sweden‑based biopharmaceutical company specializing in the discovery and development of disease‑modifying treatments for neurodegenerative disorders. The Company’s primary focus is on conditions that ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue74.24m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Balance sheet 2025

Total assetsSEK 2.58bn
Total liabilitiesSEK 608.15m
Net debt-SEK 2.15bn

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.